Actively Recruiting
A Study on the Preference of Risperidone Dosage Forms
Led by Shanghai Mental Health Center · Updated on 2024-10-24
1000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to understand the needs and preferences of patients and their caregivers regarding different forms of antipsychotic medications, specifically focusing on risperidone. It seeks to clarify the clinical value of a patch-form antipsychotic for conditions such as schizophrenia, bipolar disorder, autism spectrum disorder, conduct disorder, and mental retardation. The study is observational and sponsored by the Shanghai Mental Health Center. Participants include patients diagnosed with the mentioned psychiatric disorders or their primary caregivers. The study observes their preferences for risperidone dosage forms, particularly the patch form, without administering any investigational treatment. The study is planned to last for about six months, during which researchers will track patient and caregiver preferences. During the study, participants will be asked about their preferences for risperidone patch-form medicine and related factors influencing these preferences. Researchers will collect data through questionnaires or interviews over the six-month period. The primary measure is the proportion of patients and caregivers who prefer the patch form, with secondary measures focusing on factors influencing this preference. Participation involves ongoing observation without intervention, ensuring safety and respect for individual choices.
CONDITIONS
Brief Title
A Study on the Preference of Risperidone Dosage Forms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.
You will not qualify if you...
- Have difficulty reading and understanding Chinese or refuse to participate in the study.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Approximately 6 months
Participants are observed to understand their needs and preferences for antipsychotic dosage forms over time.
Follow-up visits as scheduled during the study period
Trial Site Locations
Total: 1 location
1
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China, 200030
Actively Recruiting
Research Team
L
Lan Luo, Doctor of Medicine
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here